IL131670A - Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders - Google Patents

Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Info

Publication number
IL131670A
IL131670A IL13167098A IL13167098A IL131670A IL 131670 A IL131670 A IL 131670A IL 13167098 A IL13167098 A IL 13167098A IL 13167098 A IL13167098 A IL 13167098A IL 131670 A IL131670 A IL 131670A
Authority
IL
Israel
Prior art keywords
manufacture
bridge
hydrogen
treatment
pharmaceutical composition
Prior art date
Application number
IL13167098A
Other languages
English (en)
Other versions
IL131670A0 (en
Original Assignee
Addex Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Addex Pharmaceuticals Sa filed Critical Addex Pharmaceuticals Sa
Publication of IL131670A0 publication Critical patent/IL131670A0/xx
Publication of IL131670A publication Critical patent/IL131670A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13167098A 1997-03-12 1998-03-11 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders IL131670A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK26597 1997-03-12
US4150997P 1997-03-24 1997-03-24
PCT/DK1998/000088 WO1998040072A1 (en) 1997-03-12 1998-03-11 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Publications (2)

Publication Number Publication Date
IL131670A0 IL131670A0 (en) 2001-01-28
IL131670A true IL131670A (en) 2005-07-25

Family

ID=26063641

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13167098A IL131670A (en) 1997-03-12 1998-03-11 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Country Status (16)

Country Link
US (1) US6211173B1 (de)
EP (1) EP1011679B1 (de)
JP (1) JP2001515484A (de)
AT (1) ATE245986T1 (de)
AU (1) AU742873B2 (de)
BR (1) BR9808234A (de)
CA (1) CA2283083C (de)
CZ (1) CZ296464B6 (de)
DE (1) DE69816832T2 (de)
DK (1) DK1011679T3 (de)
ES (1) ES2203933T3 (de)
IL (1) IL131670A (de)
NO (1) NO324719B1 (de)
PL (1) PL189822B1 (de)
PT (1) PT1011679E (de)
WO (1) WO1998040072A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035504A2 (en) * 2003-05-22 2005-04-21 Schering Corporation 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
WO2005060968A1 (en) * 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
US20050215521A1 (en) * 2003-12-22 2005-09-29 Karim Lalji Modafinil combination therapy for improving sleep quality
EP1696959A2 (de) * 2003-12-24 2006-09-06 Sepracor, Inc. Melatonin-kombinationstherapie zur verbesserung der schlafqualität
CA2556870C (en) * 2004-02-18 2014-01-28 Timothy J. Barberich Dopamine-agonist combination therapy for improving sleep quality

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK325188D0 (da) 1988-06-15 1988-06-15 Novo Industri As Hidtil ukendte benzazepinderivater
US5470850A (en) 1992-02-24 1995-11-28 Novo Nordisk A/S 2,3,4,5-tetrahydro-1H-3-benzazepines
DK26793D0 (da) 1993-03-10 1993-03-10 Novo Nordisk As Benzofuranyl- eller dihydrobenzofuranyl-substituerede tricycliske benzazepiner, der anvendelse og fremstilling

Also Published As

Publication number Publication date
IL131670A0 (en) 2001-01-28
CA2283083C (en) 2007-09-04
JP2001515484A (ja) 2001-09-18
EP1011679B1 (de) 2003-07-30
AU742873B2 (en) 2002-01-17
AU6610098A (en) 1998-09-29
ATE245986T1 (de) 2003-08-15
BR9808234A (pt) 2000-05-16
DE69816832D1 (de) 2003-09-04
CZ317799A3 (cs) 2000-03-15
PL335545A1 (en) 2000-04-25
PT1011679E (pt) 2003-12-31
DK1011679T3 (da) 2003-11-24
CZ296464B6 (cs) 2006-03-15
NO994343D0 (no) 1999-09-07
US6211173B1 (en) 2001-04-03
CA2283083A1 (en) 1998-09-17
NO994343L (no) 1999-11-11
NO324719B1 (no) 2007-12-03
DE69816832T2 (de) 2004-05-27
EP1011679A1 (de) 2000-06-28
ES2203933T3 (es) 2004-04-16
WO1998040072A1 (en) 1998-09-17
PL189822B1 (pl) 2005-09-30

Similar Documents

Publication Publication Date Title
TW347387B (en) Piperidine derivatives
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
MY109337A (en) Phenoxyl-and phenoxyalkyl-piperidines as antiviral agents
MX9800718A (es) Derivados de 2-(4-substituidos)-bencilamino-2-metil- propanamida.
JO2321B1 (en) 4-phenyl-pyridine derivatives
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
NZ514542A (en) Vasopressin antagonists for the treatment of pulmonary hypertension
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
TW340109B (en) Amide derivatives and their therapeutic use
IL131670A0 (en) Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
AU3386299A (en) N-aryloxyethylamine derivatives for the treatment of depression
UA66888C2 (uk) 3-тетрагідропіридин-4-іл індоли, спосіб їх отримання та спосіб лікування психічних розладів
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
NO973340L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
TR200001926T2 (tr) Vasküler başağrılarına karşı lokal anesteziklerin yeni kullanımı
ATE158301T1 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
PT1049672E (pt) Derivados de azetidinocarboxamida para o tratamento de disturbios do snc
GB9519883D0 (en) New cephem compounds
HUT76060A (en) A process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives
SE9603284D0 (sv) New compounds
DE69525145D1 (en) Carbamoylmethylharnstoffderivate
MX9705218A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de ginecomastia idiopatica o fisiologica.
PT1140919E (pt) Novos derivados de ciclohexano 1,4-dissubstituido para o tratamento da depressao
TW289019B (de)
MX9705390A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales.

Legal Events

Date Code Title Description
HP Change in proprietorship
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees